Literature DB >> 23988406

Prevalence and disease burden of hyperhidrosis in the adult population.

M Augustin1, M A Radtke, K Herberger, T Kornek, H Heigel, I Schaefer.   

Abstract

BACKGROUND: Although hyperhidrosis is a common and burdensome condition, little is known about the population-based prevalence.
OBJECTIVE: To evaluate the epidemiology, disease burden and medical care of hyperhidrosis in German adults.
METHODS: Employees of fifty-two companies underwent skin screenings and interviews including hyperhidrosis questions.
RESULTS: 14,336 individuals were investigated (36% women, mean age 42 years) of whom 2,340 (16.3%) reported hyperhidrosis, including 869 (6.1%) with frequent or continuous disturbing sweating. 28% showed focal hyperhidrosis, whilst 68% had a generalized condition. Predictors of hyperhidrosis were male gender and concomitant drug medication. Moreover, persons with psoriasis and with metabolic comorbidity were at increased risk. Only 27% of those with focal hyperhidrosis had consulted a physician, and only 28% used prescribed medication or self-medication.
CONCLUSION: Hyperhidrosis is a frequent skin condition predicted by medical and personal factors. In spite of the disease burden, few individuals utilize medical care. Affected individuals should be encouraged to refer to a dermatologist.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23988406     DOI: 10.1159/000351292

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  19 in total

1.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 2.  Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art.

Authors:  Anna Campanati; Stamatis Gregoriou; George Kontochristopoulos; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2015-01-30

3.  Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan.

Authors:  Tomoko Fujimoto; Yuri Inose; Hideki Nakamura; Yoshinobu Kikukawa
Journal:  Arch Dermatol Res       Date:  2022-06-29       Impact factor: 3.017

4.  Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects.

Authors:  Sanna-Liisa Heiskanen; Jani Niskala; Jari Jokelainen; Kaisa Tasanen; Laura Huilaja; Suvi-Päivikki Sinikumpu
Journal:  Acta Derm Venereol       Date:  2022-02-28       Impact factor: 3.875

5.  Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver.

Authors:  Yudan Liu; Rayeheh Bahar; Sunil Kalia; Rachel Yuanshen Huang; Arlie Phillips; Mingwan Su; Sen Yang; Xuejun Zhang; Pingyu Zhou; Youwen Zhou
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

6.  Hyperhidrosis: an update on prevalence and severity in the United States.

Authors:  James Doolittle; Patricia Walker; Thomas Mills; Jane Thurston
Journal:  Arch Dermatol Res       Date:  2016-10-15       Impact factor: 3.017

7.  Epidemiologic analysis of prevalence of the hyperhidrosis.

Authors:  Fernanda Alvarenga Estevan; Marina Borri Wolosker; Nelson Wolosker; Pedro Puech-Leão
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

8.  The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation.

Authors:  P Kamudoni; B Mueller; J Halford; A Schouveller; B Stacey; M S Salek
Journal:  Health Qual Life Outcomes       Date:  2017-06-08       Impact factor: 3.186

9.  Epidemiology of Vitiligo - A Dual Population-Based Approach.

Authors:  Nicole Mohr; Jana Petersen; Natalia Kirsten; Matthias Augustin
Journal:  Clin Epidemiol       Date:  2021-05-26       Impact factor: 4.790

10.  Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.

Authors:  Sônia Oliveira Lima; João Fernandes Britto Aragão; José Machado Neto; Kaio Bernardes Santos de Almeida; Layla Melize Santos Menezes; Vanessa Rocha Santana
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.